Working to Eradicate Gynecologic Cancers

Masaki Mandai, MD, PhD.

Department of Obstetrics and Gynecology
Kinki University
377-2, Oonohigashi, Osakasayama
Osakasayama Japan 589-8511

Papers:
52 Durable anti-tumor response of nivolumab (anti-PD-1 antibody) for platinum-resistant ovarian cancer; phase II clinical trial with nivolumab